Spinal cord ependymoma: A positron emission tomographic study with (11C-methyl)-L-methionine

Neuroradiology

Volumn 38, Issue 1, 1996, Pages 53-55

  Sasajima, T ^a   Mineura, K ^a   Itoh, Y ^a   Kowada, M ^a   Hatazawa, J ^b   Ogawa, T ^b   Uemura, K ^b  

^a AKITA UNIVERSITY HOSPITAL   (Japan)

^b RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

Author keywords

(11C methyl) L methionine; Positron emission tomography; Spinal cord ependymoma

Indexed keywords

CARBON 11; METHIONINE; TRACER;

AGED; ARTICLE; CASE REPORT; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; EPENDYMOMA; HUMAN; MALE; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SPINAL CORD TUMOR; TUMOR DIAGNOSIS;

AGED; CARBON RADIOISOTOPES; EPENDYMOMA; HUMANS; MALE; METHIONINE; SPINAL CORD; SPINAL CORD NEOPLASMS; TISSUE SURVIVAL; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030069831     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf00593221     Document Type: Article

References (16)

1. 18F] fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol 22: 360-371
2. Mineura K., Yasuda T, Kowada M, Shishido F Ogawa T, Uemura K (1986) Positron emission tomographic evaluation of histological malignancy in gliomas using oxygen-15 and fluorine-18-fluorodeoxyglucose. Neurol Res 8:164-168
3. Mineura K, Yasuda T, Kowada M, Ogawa T, Shishido F, Uemura K (1987) Positron emission tomographic evaluation of radiochemotherapeutic effect on regional cerebral hemocirculation and metabolism in patients with gliomas. J Neurooncol 5: 277-285
4. Patronas NJ, Di Chiro G, Kufta C, Bairamian D, Kornblith PL, Simon R. Larson SM (1985) Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 62: 816-822
5. Mineura K, Sasajima T, Kowada M, Ogawa T, Hatazawa J, Shishido F, Uemura K (1994) Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer 73: 2386-2394
6. 11C-methyl)-L-methionine uptake index. Neurol Med Chir (Tokyo) 30:997-1002
7. 11C-L-methionine positron emission tomography. J Nucl Med 32: 726-728
8. Iida H, Miura S, Kanno I, Murakami M, Takahashi K, Uemura K, Hirose Y, Amano M, Yamamoto S, Tanaka K (1989) Design and evaluation of HEADTOME-IV. A whole-body positron emission tomograph. IEEE Trans Nucl Sci 37:1006-1010
9. 18F-2-deoxyglucose in normal and pathological cases. J Comput Assist Tomogr 7: 937-945
10. Alavi A, Kramer E, Wegener W, Alavi J (1990) Magnetic resonance and fluorine-18 deoxyglucose imaging in the investigation of a spinal cord tumor. J Nucl Med 31: 360-364
11. Borbely K. Fulham MJ, Brooks RA, Di Chiro G (1992) PET-fluorodeoxyglucose of cranial and spinal neuromas. J Nucl Med 33: 1931-1934
12. 11C-methionine. J Comput Assist Tomogr 14: 297-299
13. Leskinen-Kallio S, Ruotsalainen U, Någren K, Teräs M, Joensuu H (1991) Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study. J Nucl Med 32: 1211-1218
14. Sze G, Krol G, Zimmerman RD, Deck MDF (1988) Intramedullary disease of the spine: diagnosis using gadolinium-DTPA enhanced MR imaging. AJNR 9: 847-858
15. Dillon WP, Norman D, Newton TH, Bolla K, Mark A (1989) Intradural spinal cord lesions: Gd-DTPA-enhanced MR imaging. Radiology 170: 229-237
16. Parizel PM, Balériaux D, Rodesch G, Segebarth C, Lalmand B, Christophe C, Lemort M, Haesendonck P, Niendorf HP, Flament-Durand J, Brotchi J (1989) Gd-DTPA-enhanced MR imaging of spinal tumors. AJR 152: 1087-1096